Aethlon Medical, Inc. (AEMD)
USD 0.33
(-5.27%)
USD 0.33
(-5.27%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -12.2 Million USD | -1.48% |
| 2023 | -12.02 Million USD | -15.49% |
| 2022 | -10.41 Million USD | -32.07% |
| 2021 | -7.88 Million USD | -23.73% |
| 2020 | -6.37 Million USD | -2.89% |
| 2019 | -6.19 Million USD | -9.07% |
| 2018 | -5.67 Million USD | 21.94% |
| 2017 | -7.27 Million USD | -49.34% |
| 2016 | -4.87 Million USD | 28.32% |
| 2015 | -6.79 Million USD | 49.11% |
| 2014 | -13.35 Million USD | -173.04% |
| 2013 | -4.89 Million USD | 39.69% |
| 2012 | -8.11 Million USD | -42.02% |
| 2011 | -5.71 Million USD | -24.89% |
| 2010 | -4.57 Million USD | 24.83% |
| 2009 | -6.08 Million USD | -46.95% |
| 2008 | -4.14 Million USD | 31.28% |
| 2007 | -6.02 Million USD | -106.31% |
| 2006 | -2.92 Million USD | -39.26% |
| 2005 | -2.09 Million USD | -38.07% |
| 2004 | -1.51 Million USD | 38.29% |
| 2003 | -2.46 Million USD | 38.41% |
| 2002 | -3.99 Million USD | 9.66% |
| 2001 | -4.42 Million USD | -240.4% |
| 2000 | -1.29 Million USD | -268.43% |
| 1999 | -352.67 Thousand USD | -9699.36% |
| 1998 | -3599.00 USD | -134.62% |
| 1997 | -1534.00 USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -3.03 Million USD | 7.55% |
| 2024 Q1 | -3.28 Million USD | -33.05% |
| 2024 Q4 | -2.42 Million USD | 30.03% |
| 2024 FY | -12.2 Million USD | -1.48% |
| 2024 Q3 | -3.46 Million USD | -14.23% |
| 2023 Q3 | -2.84 Million USD | 25.15% |
| 2023 Q1 | -2.9 Million USD | 23.23% |
| 2023 Q2 | -3.8 Million USD | -31.03% |
| 2023 FY | -12.02 Million USD | -15.49% |
| 2023 Q4 | -2.46 Million USD | 13.43% |
| 2022 FY | -10.41 Million USD | -32.07% |
| 2022 Q1 | -2.09 Million USD | 7.32% |
| 2022 Q2 | -2 Million USD | 4.26% |
| 2022 Q4 | -3.78 Million USD | -49.86% |
| 2022 Q3 | -2.52 Million USD | -25.78% |
| 2021 FY | -7.88 Million USD | -23.73% |
| 2021 Q2 | -1.77 Million USD | -25.55% |
| 2021 Q4 | -2.26 Million USD | 7.37% |
| 2021 Q3 | -2.44 Million USD | -37.97% |
| 2021 Q1 | -1.41 Million USD | 20.9% |
| 2020 Q4 | -1.78 Million USD | -117.54% |
| 2020 Q1 | -2.06 Million USD | -25.84% |
| 2020 FY | -6.37 Million USD | -2.89% |
| 2020 Q2 | -1.7 Million USD | 17.49% |
| 2020 Q3 | -819.58 Thousand USD | 51.93% |
| 2019 Q1 | -1.14 Million USD | 13.09% |
| 2019 Q2 | -1.39 Million USD | -21.56% |
| 2019 Q3 | -2.01 Million USD | -44.48% |
| 2019 Q4 | -1.64 Million USD | 18.43% |
| 2019 FY | -6.19 Million USD | -9.07% |
| 2018 FY | -5.67 Million USD | 21.94% |
| 2018 Q3 | -1.21 Million USD | 6.82% |
| 2018 Q2 | -1.3 Million USD | 29.2% |
| 2018 Q1 | -1.84 Million USD | -9.25% |
| 2018 Q4 | -1.31 Million USD | -8.55% |
| 2017 Q4 | -1.68 Million USD | -39.81% |
| 2017 FY | -7.27 Million USD | -49.34% |
| 2017 Q3 | -1.2 Million USD | 46.54% |
| 2017 Q2 | -2.25 Million USD | -5.95% |
| 2017 Q1 | -2.12 Million USD | -70.64% |
| 2016 FY | -4.87 Million USD | 28.32% |
| 2016 Q3 | -1.21 Million USD | 0.61% |
| 2016 Q2 | -1.22 Million USD | -3.51% |
| 2016 Q4 | -1.24 Million USD | -2.49% |
| 2016 Q1 | -1.18 Million USD | -33.42% |
| 2015 Q4 | -886.71 Thousand USD | 42.81% |
| 2015 FY | -6.79 Million USD | 49.11% |
| 2015 Q1 | -3.65 Million USD | 51.08% |
| 2015 Q2 | -847.4 Thousand USD | 76.82% |
| 2015 Q3 | -1.55 Million USD | -82.96% |
| 2014 Q1 | -303.49 Thousand USD | 89.03% |
| 2014 Q2 | -3.34 Million USD | -1003.69% |
| 2014 Q3 | -2.23 Million USD | 33.41% |
| 2014 Q4 | -7.47 Million USD | -235.05% |
| 2014 FY | -13.35 Million USD | -173.04% |
| 2013 Q4 | -2.76 Million USD | -981.32% |
| 2013 FY | -4.89 Million USD | 39.69% |
| 2013 Q1 | -1.01 Million USD | 77.39% |
| 2013 Q2 | -1.42 Million USD | -39.79% |
| 2013 Q3 | 313.94 Thousand USD | 122.09% |
| 2012 FY | -8.11 Million USD | -42.02% |
| 2012 Q2 | -453.47 Thousand USD | 82.46% |
| 2012 Q1 | -2.58 Million USD | -208.03% |
| 2012 Q3 | -574.71 Thousand USD | -26.74% |
| 2012 Q4 | -4.49 Million USD | -682.51% |
| 2011 Q4 | 2.39 Million USD | 228.13% |
| 2011 Q1 | -3.49 Million USD | -155.88% |
| 2011 FY | -5.71 Million USD | -24.89% |
| 2011 Q2 | -2.74 Million USD | 21.56% |
| 2011 Q3 | -1.86 Million USD | 31.86% |
| 2010 Q3 | -1.48 Million USD | -104.75% |
| 2010 Q4 | -1.36 Million USD | 8.07% |
| 2010 Q1 | -995.93 Thousand USD | -7.32% |
| 2010 Q2 | -725.7 Thousand USD | 27.13% |
| 2010 FY | -4.57 Million USD | 24.83% |
| 2009 Q2 | -1.81 Million USD | -81.5% |
| 2009 Q1 | -998.81 Thousand USD | -33.9% |
| 2009 Q3 | -2.34 Million USD | -29.33% |
| 2009 Q4 | -927.96 Thousand USD | 60.42% |
| 2009 FY | -6.08 Million USD | -46.95% |
| 2008 Q1 | -536.19 Thousand USD | 87.34% |
| 2008 Q2 | -255.05 Thousand USD | 52.43% |
| 2008 Q3 | -2.6 Million USD | -920.61% |
| 2008 FY | -4.14 Million USD | 31.28% |
| 2008 Q4 | -745.93 Thousand USD | 71.34% |
| 2007 Q4 | -4.23 Million USD | -683.52% |
| 2007 FY | -6.02 Million USD | -106.31% |
| 2007 Q3 | -540.75 Thousand USD | 13.84% |
| 2007 Q2 | -627.65 Thousand USD | -1.37% |
| 2007 Q1 | -619.15 Thousand USD | 27.2% |
| 2006 Q1 | -802 Thousand USD | -20.86% |
| 2006 FY | -2.92 Million USD | -39.26% |
| 2006 Q4 | -850.48 Thousand USD | -43.09% |
| 2006 Q3 | -594.37 Thousand USD | 11.72% |
| 2006 Q2 | -673.32 Thousand USD | 16.04% |
| 2005 Q1 | -481.33 Thousand USD | 0.83% |
| 2005 FY | -2.09 Million USD | -38.07% |
| 2005 Q2 | -348.6 Thousand USD | 27.58% |
| 2005 Q3 | -603.42 Thousand USD | -73.1% |
| 2005 Q4 | -663.58 Thousand USD | -9.97% |
| 2004 FY | -1.51 Million USD | 38.29% |
| 2004 Q3 | -328.08 Thousand USD | -14.26% |
| 2004 Q1 | -287.13 Thousand USD | 71.54% |
| 2004 Q2 | -287.13 Thousand USD | 0.0% |
| 2004 Q4 | -485.38 Thousand USD | -47.94% |
| 2003 FY | -2.46 Million USD | 38.41% |
| 2003 Q4 | -1 Million USD | -148.35% |
| 2003 Q2 | -646.68 Thousand USD | -62.01% |
| 2003 Q3 | -406.27 Thousand USD | 37.18% |
| 2003 Q1 | -399.16 Thousand USD | 80.0% |
| 2002 Q4 | -1.99 Million USD | -221.62% |
| 2002 Q3 | -620.62 Thousand USD | 14.33% |
| 2002 Q2 | -724.39 Thousand USD | -9.83% |
| 2002 Q1 | -659.58 Thousand USD | 69.2% |
| 2002 FY | -3.99 Million USD | 9.66% |
| 2001 Q1 | -626.44 Thousand USD | -16.52% |
| 2001 Q4 | -2.14 Million USD | -127.39% |
| 2001 FY | -4.42 Million USD | -240.4% |
| 2001 Q3 | -941.65 Thousand USD | -31.93% |
| 2001 Q2 | -713.74 Thousand USD | -13.94% |
| 2000 Q2 | -257.05 Thousand USD | -44.32% |
| 2000 Q4 | -537.62 Thousand USD | -64.62% |
| 2000 Q3 | -326.59 Thousand USD | -27.05% |
| 2000 Q1 | -178.11 Thousand USD | 0.0% |
| 2000 FY | -1.29 Million USD | -268.43% |
| 1999 FY | -352.67 Thousand USD | -9699.36% |
| 1998 FY | -3599.00 USD | -134.62% |
| 1997 FY | -1534.00 USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 80.187% |
| BrainsWay Ltd. | -4.19 Million USD | -190.879% |
| Cerus Corporation | -37.48 Million USD | 67.435% |
| Envoy Medical, Inc. | -29.9 Million USD | 59.181% |
| electroCore, Inc. | -18.83 Million USD | 35.18% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | -37.945% |
| IceCure Medical Ltd | -14.65 Million USD | 16.679% |
| Inogen, Inc. | -102.44 Million USD | 88.084% |
| OrthoPediatrics Corp. | -20.97 Million USD | 41.794% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 76.82% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | 11.182% |
| MaxCyte, Inc. | -37.92 Million USD | 67.808% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | -2.94% |
| Nexalin Technology, Inc. | -4.64 Million USD | -162.614% |
| Orthofix Medical Inc. | -151.39 Million USD | 91.936% |
| PAVmed Inc | -64.17 Million USD | 80.977% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 76.732% |
| RxSight, Inc. | -48.6 Million USD | 74.884% |
| Sight Sciences, Inc. | -55.54 Million USD | 78.022% |
| SI-BONE, Inc. | -43.33 Million USD | 71.829% |
| TELA Bio, Inc. | -46.66 Million USD | 73.838% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 75.35% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | 10.122% |
| Acutus Medical, Inc. | -81.66 Million USD | 85.051% |
| Talis Biomedical Corporation | -62 Million USD | 80.312% |
| Spectral AI, Inc. | -20.85 Million USD | 41.459% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 79.913% |
| CVRx, Inc. | -41.19 Million USD | 70.368% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 2006.943% |
| PetVivo Holdings, Inc. | -10.95 Million USD | -11.436% |
| Bioventus Inc. | -156.23 Million USD | 92.186% |
| Venus Concept Inc. | -37.25 Million USD | 67.226% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 79.321% |
| LivaNova PLC | 17.54 Million USD | 169.578% |
| 908 Devices Inc. | -36.39 Million USD | 66.46% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 93.459% |
| Nemaura Medical Inc. | -14.14 Million USD | 13.685% |
| NeuroPace, Inc. | -32.95 Million USD | 62.956% |
| LENSAR, Inc. | -14.38 Million USD | 15.121% |
| Apyx Medical Corporation | -18.71 Million USD | 34.761% |
| Cutera, Inc. | -162.83 Million USD | 92.503% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | -12.726% |
| BioSig Technologies, Inc. | -29.04 Million USD | 57.962% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 85.232% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 44.732% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 118.022% |
| Axonics, Inc. | -6.08 Million USD | -100.528% |
| Outset Medical, Inc. | -172.79 Million USD | 92.935% |
| IRIDEX Corporation | -9.57 Million USD | -27.567% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 88.472% |
| IRadimed Corporation | 17.19 Million USD | 171.008% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -48.086% |
| INVO Bioscience, Inc. | -8.03 Million USD | -51.945% |
| Telesis Bio, Inc. | -47.72 Million USD | 74.419% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 219.186% |
| Varex Imaging Corporation | -47.7 Million USD | 74.406% |
| Quipt Home Medical Corp. | -2.78 Million USD | -338.512% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -8.171% |
| Pulmonx Corporation | -60.84 Million USD | 79.935% |
| Dynatronics Corporation | -2.69 Million USD | -352.537% |
| Modular Medical, Inc. | -17.47 Million USD | 30.119% |
| ReShape Lifesciences Inc. | -11.38 Million USD | -7.212% |
| Semler Scientific, Inc. | 20.58 Million USD | 159.312% |
| InMode Ltd. | 197.91 Million USD | 106.168% |
| Bruker Corporation | 427.2 Million USD | 102.858% |
| Cytosorbents Corporation | -28.5 Million USD | 57.175% |
| DexCom, Inc. | 541.5 Million USD | 102.255% |
| Align Technology, Inc. | 445.05 Million USD | 102.743% |
| Viveve Medical, Inc. | -22.02 Million USD | 44.576% |
| ZimVie Inc. | -393.28 Million USD | 96.896% |
| Movano Inc. | -29.28 Million USD | 58.31% |
| Cytek Biosciences, Inc. | -12.14 Million USD | -0.495% |
| Nexalin Technology, Inc. | -4.64 Million USD | -162.614% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 2006.943% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 94.516% |
| Profound Medical Corp. | -28.56 Million USD | 57.268% |
| Insulet Corporation | 206.3 Million USD | 105.918% |
| enVVeno Medical Corporation | -23.51 Million USD | 48.086% |
| Surmodics, Inc. | -11.54 Million USD | -5.772% |
| iCAD, Inc. | -4.84 Million USD | -151.871% |
| Nuwellis, Inc. | -20.2 Million USD | 39.59% |
| Biotricity, Inc. | -14.09 Million USD | 13.382% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 90.107% |
| InspireMD, Inc. | -19.91 Million USD | 38.702% |
| PAVmed Inc. | -64.17 Million USD | 80.977% |
| BIOLASE, Inc. | -20.63 Million USD | 40.829% |
| Beyond Air, Inc. | -60.24 Million USD | 79.735% |
| FONAR Corporation | 10.56 Million USD | 215.527% |
| AxoGen, Inc. | -21.71 Million USD | 43.783% |
| Vivani Medical, Inc. | -25.65 Million USD | 52.408% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 142.813% |
| Inari Medical, Inc. | -1.63 Million USD | -646.221% |
| UFP Technologies, Inc. | 44.92 Million USD | 127.175% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -137.868% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | -84.826% |
| Tenon Medical, Inc. | -15.58 Million USD | 21.647% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | 20.86% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 65.448% |
| AdaptHealth Corp. | -678.89 Million USD | 98.202% |
| Sintx Technologies, Inc. | -8.25 Million USD | -47.817% |
| NanoVibronix, Inc. | -3.71 Million USD | -228.973% |
| Quanterix Corporation | -32.33 Million USD | 62.244% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -8.171% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 2617.149% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 96.02% |
| TransMedics Group, Inc. | -25.02 Million USD | 51.222% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 44.842% |
| NeuroMetrix, Inc. | -6.52 Million USD | -86.97% |
| Hyperfine, Inc. | -44.23 Million USD | 72.403% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 84.449% |
| Biomerica, Inc. | -5.97 Million USD | -104.218% |
| Bone Biologics Corporation | -8.94 Million USD | -36.424% |
| AVITA Medical, Inc. | -39.16 Million USD | 68.831% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | -22.647% |
| Silk Road Medical, Inc | -55.74 Million USD | 78.099% |